Affymetrix,
Inc. (NASDAQ: AFFX) will be highlighting several new genotyping
arrays at the 2015 Plant and Animal Genome Conference (PAGXXIII) for
applications in breeding and routine analysis. Affymetrix now offers the
largest catalog of arrays for research and applied agriculture markets.
The newest arrays, Axiom® Porcine Genotyping Array and Axiom
Equine Genotyping Array, each with more than 600,000 markers, will be
available to the agriculture community under the Axiom Expert Design
Program. These two high-density arrays add to the product portfolio that
includes bovine, chicken, maize, salmon, and wheat. Affymetrix has
recently launched arrays with the newest content for genomic breeding in
soybean and cotton, and arrays for buffalo, rainbow trout, rose, and
strawberry. Also new are enhanced wheat arrays that have come out of the
UK-based Wheat Institute Strategic Programme (WISP), which began using
Axiom arrays early last year.
“Axiom genotyping technology offers the agriculture community the
capabilities to rapidly design and develop custom arrays,” said Dr.
Laurent Bellon, Senior Vice President and General Manager of Genetic
Analysis Business Unit at Affymetrix. “Array-based genotyping empowers
the agriculture community around the world with powerful yet easy-to-use
genomic tools to rapidly address the challenges posed by the growing
food requirements of our world.”
The arrays will be featured at the Affymetrix workshop that will include
three talks from industry experts on Monday, January 12 at PAG XXIII.
The talks will cover the latest genomic techniques for research and
breeding in pigs, strawberry, and Medicago truncatula. Affymetrix
is at the forefront of plant and animal genotyping and gene expression
analysis with Axiom genotyping arrays and GeneChip® gene
expression arrays for more than 50 plant and animal species.
With Affymetrix’ advanced bioinformatics and innovative design
strategies, Axiom arrays routinely support genome-wide genotyping and
accurately call the genotypes of both diploid and polyploid species.
The catalog of Axiom agrigenomics genotyping arrays, gene expression
arrays, reagents, and powerful bioinformatics software that can address
diploid and polyploid genomes gives scientists the toolbox to advance
their research and commercial objectives by translating discoveries to
routine applications.
To learn more about the Axiom Genotyping Solution for applications in
agrigenomics, please visit www.affymetrix.com/agrigenomics.
PLEASE NOTE: The Affymetrix logo, Affymetrix, Axiom, and GeneChip
are registered trademarks of Affymetrix, Inc. All other trademarks and
names are the property of their respective owners.
About Affymetrix
Affymetrix technologies enable multiplex and simultaneous analysis of
biological systems at the cell, protein, and gene level, facilitating
the rapid translation of bench-top research into clinical and routine
use for human health and wellness. The Company provides leadership and
support, partnering with customers in pharmaceutical, diagnostic, and
biotechnology companies, as well as leading academic, government, and
non-profit research institutes in their quest to use biology for a
better world. More than 2,300 microarray systems have been shipped
around the world and more than 94,500 peer-reviewed papers have been
published citing Affymetrix technologies. Affymetrix is headquartered in
Santa Clara, California, and has manufacturing facilities in Cleveland,
Ohio, San Diego, Vienna, and Singapore. The Company has about 1,100
employees worldwide and maintains sales and distribution operations
across Europe, Asia, and Latin America. For more information about
Affymetrix, please visit www.affymetrix.com.
Forward-looking statements
All statements in this press release that are not historical are
"forward-looking statements" within the meaning of Section 21E of the
Securities Exchange Act as amended, including statements regarding
Affymetrix' "expectations," "beliefs," "hopes," "intentions,"
"strategies," or the like. Such statements are subject to risks and
uncertainties that could cause actual results to differ materially for
Affymetrix from those projected. These and other risk factors are
discussed in Affymetrix' Form 10-K for the year ended December 31, 2013,
and other SEC reports for subsequent quarterly periods.
Copyright Business Wire 2015